[Experience of treatment of patients with myocardial infarction without raise of ST segment on ECG of high risk of cardiocomplications by method of coronary angioplasty].
There was realized a risk-stratification in accord with elaborated evaluative hazard rating of cordial complications during effectuating of transcutaneous coronary operations (TCO) by 109 patients with myocardial infarction without increasing of ST segment on ECG (MIWIST). There were marked 2 groups: group of the 1st and the 2nd stage of risk with using of 2-component (aspirin+klopidogrel) and 3-component (aspirin+klopidogrel+blocker of glycoprotein IIb/IIIa receptors of thrombocytes) ancillary contra-thrombocyte therapy (CTT). Was concluded, that in conditions of effectuating of TCO by patients with MIWIST, relating to the 1st stage of risk of cordial complications in accord with elaborated evaluative hazard rating, 2-component CTT permits achieve 100% of clinical-angiographic effect; there was showed using of 3-component CTT among patients of the 2nd stage of risk.
A B
AB
Shames
V A
VA
Igonin
V V
VV
Krashutskiĭ
V A
VA
Ivanov
S A
SA
Terekhin
D000077284:Abciximab; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D001241:Aspirin / Q000008:administration & dosage*; D000077144:Clopidogrel; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000503:physiopathology / Q000628:therapy*; D010975:Platelet Aggregation Inhibitors; D012189:Retrospective Studies; D012307:Risk Factors; D013988:Ticlopidine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin; D000077284:Abciximab